Skip to main content
lexblog.com/lib/BXFYPS54viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "New Opportunities, New Challenges: FDA Elaborates on use of Digital Health in Drug and Biological Product Development",
    "url": "https://www.lexblog.com/2023/04/21/new-opportunities-new-challenges-fda-elaborates-on-use-of-digital-health-in-drug-and-biological-product-development/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-BXFYPS54",
        "url": "https://www.lexblog.com/lib/BXFYPS54/"
    },
    "datePublished": "2023-04-21T10:40:21-04:00",
    "dateModified": "2023-04-21T11:06:16-04:00",
    "author": {
        "@type": "Person",
        "name": "Sarah Thompson Schick, Rebecca Jones McKnight, Vicki Tankle, Roswill Mejia"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26050",
    "sourceStability": "may-move"
}